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Objective: Acutekidney injury (AKI) is a serious complicationafter repair of a ruptured abdominal aortic aneurysm(RAAA). In
the present Society for Vascular Surgery (SVS)/International Society for CardioVascular Surgery (ISCVS) reporting stan-
dards patients are classiﬁed as no dialysis (grade I), as temporary dialysis (grade II), and as permanent dialysis or fatal outcome
(grade III). However, AKI is a broad clinical syndrome including more than the requirement for renal replacement therapy.
The recently introduced ‘Risk,’ ‘Injury,’ ‘Failure,’ ‘Loss,’ and ‘End-stage’ (RIFLE) classiﬁcation for AKI comprises three
severity categories based on serum creatinine and urine output (‘Risk,’ ‘Injury,’ and ‘Failure’). The objective of the present
studywas to assess the incidence ofAKIusing theRIFLEcriteria (AKIRIFLE). Secondaryobjectiveswere to assess the incidence
ofAKIasdeﬁnedusing theSVS/ISCVSreporting standards (AKISVS/ISCVS) and the associationbetweenAKIRIFLE anddeath.
Methods: This was an observational cohort study in 362 consecutive patients with an RAAA in three hospitals
in Amsterdam (The Netherlands) between 2004 and 2011. The end points were the incidence of AKIRIFLE, of
AKISVS/ISCVS, and the combined 30-day or in-hospital death rate. A multivariable logistic regression model was made to
assess the association between AKIRIFLE and death after adjustment for preoperative shock proﬁle (Glasgow Aneurysm
Score) and postoperative shock proﬁle (Acute Physiology and Chronic Health Evaluation [APACHE] II score, use of
vasopressors, and ﬂuid balance during the ﬁrst 24 hours after intervention).
Results: AKIRIFLE occurred in 74% (267/362; 95% conﬁdence interval [CI], 69%-78%), with 27% of these patients cate-
gorized as ‘Risk’ (71/267; 95% CI, 22%-32%), 39% categorized as ‘Injury’ (104/267, 95% CI, 33%-45%), and 34% cate-
gorized as ‘Failure’ (92/267; 95%CI, 29%-40%).AKISVS/ISCVS occurred in 48% (175/362; 95%CI, 43%-53%),with 53%of
these categorized as ‘grade I’ (92/175; 95%CI, 45%-60%), 19% as ‘grade II’ (34/175; 95%CI, 14%-26%), and 28% as ‘grade
III’ (49/175; 95% CI, 22%-35%). After multivariable adjustment for shock proﬁles the risk of dying in patients categorized
as AKIRIFLE ‘Failure’ was greater than in patients without AKIRIFLE (adjusted odds ratio, 6.360; 95% CI, 2.231-18.130).
Conclusions: The incidence of AKI deﬁned according to the RIFLE criteria (74%) was greater than deﬁned using the SVS/
ISCVS reporting standards (48%) and patients categorized as ‘Failure’ using the RIFLE criteria had a greater risk of dying
than patients without AKI. These results indicate that the problem of AKI is much bigger than previously anticipated and
that minimizing injury to the kidney could be an important focus of future research on reducing the death rate after
RAAA repair. (J Vasc Surg 2014;60:1159-67.)Acute kidney injury (AKI) is a serious complication of The reporting standards by the Society for Vascular
repair for a ruptured abdominal aortic aneurysm (RAAA).
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Table I. The ‘Risk,’ ‘Injury,’ ‘Failure,’ ‘Loss,’ and ‘End-stage’ (RIFLE) criteria and the Society for Vascular Surgery/
International Society for CardioVascular Surgery (SVS/ISCVS) reporting standards for acute kidney injury (AKI)5,8
Category RIFLE SCr criteriaa RIFLE urine output criteria
Risk Increase $1.5 times from baseline or GFR decrease >25% <0.5 mL/kg/h $6 hours
Injury Increase $2 times from baseline or GFR decrease >50% <0.5 mL/kg/h $12 hours
Failure Increase $ 3 times from baseline or GFR decrease >75% or
$354 mmol/L with an acute increase $44 mmol/L from
baseline
<0.3 mL/kg/h $24 hours or anuria $12 hours
Loss Complete loss of kidney function >4 weeks
End-stage Complete loss of kidney function >3 months
SVS/ISCVS reporting standards SVS/ISCVS reporting standards in the present study
I No dialysis SCr >159 mmol/L within 7 days after admission
II Temporary dialysis, prolonged hospitalization, permanently
reduced renal function
Temporary dialysis
III Permanent dialysis, transplant, or fatal outcome Permanent dialysis or temporary dialysis with fatal
outcome
GFR, Glomerular ﬁltration rate; SCr, serum creatinine.
For the RIFLE criteria, only one criterion (SCr or urine output) has to be fulﬁlled to qualify for a category. Patients are classiﬁed based on the criterion that
places them in the worst category.
aBased on change between two SCr values within 7 days after admission.
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the Acute Dialysis Quality Initiative group introduced the
‘Risk,’ ‘Injury,’ ‘Failure,’ ‘Loss,’ and ‘End-stage’ (RIFLE)
criteria for AKI based on serum creatinine (SCr) and urine
output criteria (Table I).8 The aim of this multidisciplinary
consensus classiﬁcation was to standardize the deﬁnition of
AKI for clinical and research purposes and to reﬂect the
complete spectrum of the disease. The RIFLE classiﬁcation
is the ﬁrst widely accepted deﬁnition for AKI and has been
validated in more than half a million patients worldwide.9-
11 Even mild, reversible AKI deﬁned using the RIFLE
criteria has important clinical consequences including an
increased risk of short-term death9 and worse long-term
survival.12 Therefore, in daily practice the RIFLE criteria
can be used to identify high-risk patients. To date, only
two smaller retrospective studies have applied the RIFLE
criteria to patients with an RAAA.13,14
The primary objective of the present study was to assess
the incidence of AKI in a large cohort of RAAA patients
deﬁned using the RIFLE criteria (AKIRIFLE). Secondary ob-
jectives were to assess the incidence of AKI deﬁned using the
SVS/ISCVS reporting standards (AKISVS/ISCVS), to assess he
association between AKIRIFLE and death, and to assess the
need for RRT (in-hospital and permanent after discharge).METHODS
The present study is a sequel to the Amsterdam Acute
Aneurysm Trial (registration ISRCTN: 66212637) con-
ducted in the Amsterdam ambulance region between
2004 and 2011. Details of this study have been published
previously.7,15 In brief, care for patients with an RAAA
was centralized at the Academic Medical Centre (AMC),
the Onze Lieve Vrouwe Gasthuis (OLVG), and the VU
University Medical Centre (VUMC).The present study included all prospectively registered
consecutive patients with repair for an RAAA at the AMC,
the OLVG, and the VUMC. Patients who died during
intervention or shortly thereafter and preoperative perma-
nent dialysis patients were excluded from the analysis.
The study was conducted in accordance with the principles
of the Declaration of Helsinki. No patient consent was
needed because of the observational study design.
End points. The end points were the incidence of
AKIRIFLE, of AKISVS/ISCVS, the combined 30-day or in-
hospital death rate, temporary in-hospital RRT, and per-
manent dialysis after discharge.
RIFLE criteria. Patients were categorized as ‘no
AKI,’ ‘Risk,’ ‘Injury,’ or ‘Failure’ based on the worst SCr
and urine output category during the ﬁrst week of intensive
care unit (ICU) admission (Table I).8 The SCr category
was assessed by comparing the highest SCr with a baseline
SCr. The baseline SCr was deﬁned according to the rec-
ommendations of the RIFLE criteria and comprised ﬁve
steps (Fig 1). The most recent SCr within 1 year before
intervention (‘premorbid SCr’) and the in-hospital SCr
before intervention (‘preoperative SCr’) were collected. An
‘estimated SCr’ was calculated by solving the modiﬁcation
of diet in renal disease (MDRD) equation.16 This equation
assumes a glomerular ﬁltration rate (GFR) of 75 mL/min/
1.73 m2; SCr ¼ (75/[186  (age0.203)  (0.742 if
female)  (1.21 if black)])0.887. The ﬁrst step of the
baseline SCr approximation was to compare the ‘pre-
morbid SCr’ with the ‘preoperative SCr.’ The lowest of
these values served as the baseline SCr. The second step
was in patients with no renal comorbidity to compare the
‘estimated SCr’ with the ‘preoperative SCr.’ Again, the
lowest value of these served as the baseline SCr. The third
step was in patients with renal comorbidity to use the
‘preoperative SCr’ as baseline SCr. In three patients no
Fig 1. Method of baseline serum creatinine (SCr) approximation. The most recent SCr level within 1 year before the
intervention was used as premorbid SCr. The in-hospital SCr level before the ruptured abdominal aortic aneurysm
(RAAA) intervention was used as the preoperative SCr. Estimated SCr ¼ assuming a glomerular ﬁltration rate (GFR)
of 75 mL/min/1.73 m2, SCr ¼ (75/[186  (age  0.203)  (0.742 if female)  (1.21 if black)])  0.887. The
imputed SCr was calculated as the median baseline SCr of patients with renal comorbidity (154 mmol/L).
JOURNAL OF VASCULAR SURGERY
Volume 60, Number 5 van Beek et al 1161baseline SCr could be created in this way and the ‘preop-
erative SCr’ was used (step 4) or was imputed with the
median baseline SCr of patients with renal comorbidity
(154 mmol/L) (step 5). Renal comorbidity was deﬁned as
a previous history of chronic kidney failure. The urine
output category was estimated in blocks of 6, 12, and
24 hours and the lowest urine output was used for cate-
gorization. In patients treated with RRT, the AKI category
before start of RRT was reported.
SVS/ISCVS reporting standards. Patients were
categorized as ‘no AKI,’ ‘grade I,’ ‘grade II,’ or ‘grade
III’ (Table I).5 Based on a previous study in RAAAsreporting about AKI, patients were categorized as ‘grade
I’ if the highest SCr during the ﬁrst week of ICU
admission was >159 mmol/L (>1.8 mg/dL).3 The de-
cision to initiate RRT was based on the caregivers’
judgement of the severity of illness, the presence of oli-
guria or ﬂuid overload, the number and type of failed
nonrenal factors, and whether the patient was recovering
or deteriorating.
Data collection. Data were collected retrospectively
using Microsoft Ofﬁce Access 2003 (Microsoft Corpora-
tion, Redmond, Wash). Preoperative data were collected
from the admission charts and included age (years), sex,
JOURNAL OF VASCULAR SURGERY
1162 van Beek et al November 2014comorbidities, body mass index, lowest in-hospital systolic
blood pressure (mm Hg) and the application of cardio-
pulmonary resuscitation. The preoperative variables were
deﬁned according to the reporting standards of the SVS/
ISCVS.17 Postoperative data were collected from the
electronic charts of the ICU (iMDsoft; MetaVision,
Needham, Mass) and included daily SCr, hourly urine
output, and the initiation of RRT. The electronic charts
showed the exact urine output per hour and were ﬁlled in
prospectively by ICU staff from the start of ICU admission.
All three hospitals used continuous venovenous hemoﬁl-
tration as temporary RRT. The ﬁrst 24 hours after inter-
vention the APACHE II score, the use of vasopressors, and
the ﬂuid balance were collected. The use of vasopressors
was categorized as none (no ICU admission or no vaso-
pressors administered), low dose (noradrenalin <2 mg/min
or dopamine <500 mg/min), or high dose (any adrenalin,
noradrenalin >2 mg/min, or dopamine >500 mg/min).
The ﬂuid balance was categorized by evenly distributing
the number of patients in tertiles.
Data on patients requiring RRT after discharge was ob-
tained from the Dutch Renal Replacement Registry,
accessed on January 1, 2013 (RENINE, Leiden, The
Netherlands).18
Statistical analysis. Data were analyzed using IBM
SPSS Statistics 20.0 (SPSS Inc, Armonk, NY). Results are
presented as mean 6 standard deviation for normally
distributed data and as median with interquartile range
(IQR) for data with a skewed distribution. The statistical
analysis comprised two steps. First, the incidence of AKI
deﬁned using both deﬁnitions and corresponding death
rates were calculated. Second, a multivariable logistic
regression model was made to assess the association be-
tween AKIRIFLE and death. The model aimed to adjust
for preoperative and postoperative shock proﬁle. The Glas-
gow Aneurysm Score (GAS)19 was used as a surrogate
marker for preoperative shock proﬁle. The APACHE II
score, the use of vasopressors, and the ﬂuid balance during
the ﬁrst 24 hours after intervention were used as markers
for postoperative shock proﬁle.
To include all patients in the regression model an
imputation procedure was done using logistic and linear
regression models whereby 10 datasets were created. The
predictors in the imputation model were the baseline char-
acteristics and the level of consciousness, serum hemoglo-
bin, AKIRIFLE, and AKISVS/ISCVS, and death.
RESULTS
Between 2004 and 2011, 457 consecutive patients
with an RAAA presented at the AMC, OLVG, and
VUMC.Of these patients, 50 did not undergo intervention.
Of 407 patients eligible for inclusion, 45 were excluded
because of death during the intervention (n ¼ 32), death
within 6 hours after the intervention (n ¼ 9), charts could
not be retrieved (n ¼ 3), or preoperative permanent dialysis
(n ¼ 1). The baseline characteristics of the 362 patients
included in the analysis are shown in Table II. Sixty-
eight patients were treated with endovascular aneurysmrepair (EVAR) and 294 patients were treated with open
repair (OR). The combined 30-day or in-hospital death
rate was 27% (97/362; 95% conﬁdence interval [CI],
22%-32%). The baseline SCr was based on the ‘estimated
SCr’ in 168 patients, on the ‘preoperative SCr’ in 158 pa-
tients, on the ‘premorbid SCr’ in 35 patients, and was
imputed in one patient (Fig 1).
AKI deﬁned according to the RIFLE criteria. Seventy-
four percent of patients developed AKIRIFLE (267/362; 95%
CI, 69%-78%), with 27% categorized as ‘Risk’ (71/267;
95% CI, 22%-32%), 39% categorized as ‘Injury’ (104/267;
95% CI, 33%-45%), and 34% categorized as ‘Failure’ (92/
267; 95% CI, 29%-40%; Table III). Fig 2 shows the death
rate per RIFLE category. Multivariable adjustment showed
that patients categorized as ‘Failure’ had a higher risk of dying
(adjusted odds ratio, 6.360; 95% CI, 2.231-18.130) than
patients without AKI (Table IV).
AKI deﬁned according to the SVS/ISCVS report-
ing standards. Forty-eight percent of patients developed
AKISVS/ISCVS (175/362; 95% CI, 43%-53%), with 53% of
these categorized as ‘grade I’ (92/175; 95% CI, 45%-60%),
19% as ‘grade II’ (34/175; 95% CI, 14%-26%), and 28% as
‘grade III’ (49/175; 95% CI, 22%-35%; Table III). Fig 2
shows the death rate per SVS/ISCVS reporting standards
category.
RRT. The RRT rate during admission was 23% (83/
362; 95% CI, 19%-28%). The median duration of RRT
was 6 days (IQR, 2-14). The RRT rate during admission
was: after EVAR, 10% (7/68; 95% CI, 5%-20%) and after
OR, 26% (76/294; 95% CI, 21%-31%). The permanent
RRT rate after discharge was 2% (6/265; 95% CI, 1%-5%).
DISCUSSION
Most surgically treated RAAA patients develop AKI
deﬁned using the RIFLE criteria. The incidence of AKI
deﬁned using the RIFLE criteria was much higher (74%)
than anticipated according to the SVS/ISCVS reporting
standards (48%). A large group of patients (92/362) was
categorized as ‘Failure’ and these patients had a greater
risk of dying than patients without AKI. Therefore, in clin-
ical practice the RIFLE criteria can be used to identify
high-risk patients.
The RIFLE criteria. A direct comparison between the
RIFLE criteria and the SVS/ISCVS reporting standards is
inappropriate. The RIFLE criteria can be used to improve
risk-stratiﬁcation for clinical and research purposes and the
SVS/ISCVS reporting standards are used to score severe
complications for research purposes only. Interestingly, in
half of the patients (51%; 184/362) the SVS/ISCVS
reporting standards either did not diagnose or under-
estimated the severity of AKI compared with the RIFLE
criteria. The patients additionally identiﬁed by the RIFLE
criteria who were categorized as ‘Failure’ had a greater risk
of dying than patients without AKI after adjustment for
shock proﬁles (adjusted odds ratio ‘Failure’ vs ‘no AKI,’
3.037; 95% CI, 1.022-9.027). This underlines the clinical
importance of AKI deﬁned using the RIFLE criteria in
addition to the SVS/ISCVS reporting standards.
Table II. Baseline characteristics of 362 patients with a ruptured abdominal aortic aneurysm (RAAA)
Variable Value Missing data
Age, years 76 (69-81) 0
Sex, male/female 294/68 0
Cardiac comorbidity 42 (152/360) 1 (2/362)
Pulmonary comorbidity 23 (83/359) 1 (3/362)
Renal comorbidity 12 (42/359) 1 (3/362)
Cerebrovascular comorbidity 16 (58/360) 1 (2/362)
Diabetes 10 (37/356) 2 (6/362)
Hypertension 43 (154/358) 2 (4/362)
BMI 25.6 (23.4-27.8) 12 (42/362)
Lowest preoperative in-hospital systolic blood pressure 98 (74-128) 4 (13/362)
Preoperative cardiopulmonary resuscitation 8 (27/351) 3 (11/362)
Premorbid SCr (available in 45 patients), mmol/L 84 (64-108) 88 (317/362)
Preoperative SCr (available in 359 patients), mmol/L 104 (85-132) 1 (3/362)
Estimated SCr, mmol/L 98 (95-100) 12 (45/362)
Baseline SCr, mmol/L 96 (74-100) 0
EVAR/OR 68/294 0
Preoperative GAS 91 (81-103) 4 (16/362)
APACHE II score 19 (15-24) 8 (30/362)
Use of vasopressors 24 hours after intervention
None 33 (120/362) 0
Low dose (noradrenaline <2 mgram/min or dopamine <500 mg/min) 45 (162/362)
High dose (adrenalin, noradrenaline >2 mg/min or dopamine >500 mg/min) 22 (80/362)
Fluid balance ﬁrst 24 hours after intervention
<2 L positive 36% (132/362) 0
>2 L and <5 L positive 36% (130/362)
>5 L positive 28% (100/362)
APACHE, Acute Physiology and Chronic Health Evaluation; BMI, body mass index; EVAR, endovascular aneurysm repair; GAS, Glasgow Aneurysm Score;
GFR, glomerular ﬁltration rate; IQR, interquartile range; OR, open repair; SCr, serum creatinine.
Continuous data are presented as median (IQR) and categoric data as percentage (No.).
Premorbid SCr value was derived from the most recent SCr level within 1 year before the intervention. Preoperative SCr was the in-hospital SCr level before
the intervention for RAAA. Estimated SCr ¼ assuming a GFR of 75 mL/min/1.73 m2 and SCr ¼ (75/[186  (age0.203)  (0.742 if female)  (1.21 if
black)])0.887.
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reporting about AKI after an RAAA the RIFLE criteria
should play a central role.
With use of an electronic charts including daily SCr and
hourly urine output, patients can be categorized for the RI-
FLE criteria automatically. A baseline SCr is needed to
apply the RIFLE SCr criteria. Although there is debate
regarding the optimal methods to approximate the baseline
SCr in acute settings,20 the recommendations of the RI-
FLE criteria anticipate this issue and we adhered to it
accordingly.8 The baseline SCr has to be a recent measure,
either the ‘premorbid SCr’ or the ‘preoperative SCr.’ In
patients with no renal comorbidity and no measure of
baseline SCr, one can estimate the baseline SCr with use
of the ‘estimated SCr.’ The ‘estimated SCr’ has been
shown to be valid in patients with normal renal func-
tion.16 The RIFLE criteria give no recommendations for
baseline SCr approximation in patients with renal comor-
bidity. We used the ‘preoperative SCr’ in patients with
renal comorbidity. There are several drawbacks of the
methods of baseline SCr approximation speciﬁcally for
our study. The ‘premorbid SCr’ might have been available
in patients recently hospitalized thereby overestimating
the baseline SCr. The ‘estimated SCr’ assumes a GFR of
75 mL/min/1.73 m2, which might overestimate renal
function in patients with atherosclerotic vascular disease.The ‘preoperative SCr’ was affected by hypovolemia
thereby overestimating the baseline SCr. In our cohort
of patients the ‘premorbid SCr’ (median, 84 mmol/L;
IQR, 64-108 mmol/L), the ‘estimated SCr’ (median,
98 mmol/L; IQR, 95-100 mmol/L) and the ‘preoperative
SCr’ (median, 104 mmol/L; IQR, 85-132 mmol/L) barely
differed. This conﬁrms that the baseline SCr approximation
was accurate by adhering to the recommendations of the
RIFLE criteria.
In critically ill patients admitted to the ICU, there is a
stepwise increase of death rate per RIFLE category adjusted
for multiorgan failure.9 Fig 2 suggests an increasing death
rate per increasing AKI severity in RAAA patients. After
multivariable adjustment for shock proﬁles, this association
was not signiﬁcant for the ‘Risk’ and ‘Injury’ categories
(Table IV). It might be that after RAAA repair the short-
termnegative effects ofmild AKI are less pronounced.How-
ever, another plausible explanation for the lack of statistical
signiﬁcance is our limited sample size.
An advantage of the RIFLE criteria is that they have
been validated in other acute conditions. For example,
the incidence of AKI deﬁned using the RIFLE criteria in
patients with an RAAA is high compared with patients
with an acute myocardial infarction (15%; 95% CI,
13%-17%)10 and comparable with patients with severe
burns (62%; 95% CI, not available).11
Table III. The incidence of acute kidney injury (AKI) deﬁned according to the ‘Risk,’ ‘Injury,’ ‘Failure,’ ‘Loss,’ and
‘End-stage’ (RIFLE) criteria and according to the Society for Vascular Surgery/International Society for CardioVascular
Surgery (SVS/ISCVS) reporting standards
All patients EVAR OR
RIFLE criteria
Any AKI (No.; 95% CI) 74% (267/362; 69-78) 63% (43/68; 51-74) 76% (224/294; 71-81)
AKI category (No.; CI)
Risk 27% (71/267; 22-32) 33% (14/43; 20-47) 25% (57/224; 20-32)
Injury 39% (104/267; 33-45) 40% (17/43; 26-54) 39% (87/224; 33-45)
Failure 34% (92/267; 29-40) 28% (12/43; 17-43) 36% (80/224; 30-42)
If AKI, reason (No.; CI)
Urine output 44% (117/267; 38-50) 51% (22/43; 37-65) 42% (95/224; 36-49)
SCr 30% (80/267; 25-36) 28% (12/43; 17-43) 30% (68/224; 25-37)
Urine output and SCr 26% (70/267; 21-32) 21% (9/43; 11-35) 27% (61/224; 22-33)
Days after intervention of AKI
category, median (IQR)
3 (2-4) 3 (2-4) 3 (2-4)
SVS/ISCVS reporting
standards
Any AKI (No.; CI) 48% (175/362; 43-53) 40% (27/68; 29-52) 50% (148/294; 45-56)
AKI category (No.; CI)
I 53% (92/175; 45-60) 74% (20/27; 55-87) 49% (72/148; 41-57)
II 19% (34/175; 14-26) 11% (3/27; 4-28) 21% (31/148; 15-28)
III 28% (49/175; 22-35) 15% (4/27; 6-32%) 30% (45/148; 24-38)
Days after intervention of
AKI category, median (IQR)
3 (2-4) 3 (2-4) 3 (2-4)
CI, Conﬁdence interval; EVAR, endovascular aneurysm repair; IQR, interquartile range; OR, open repair; SCr, serum creatinine.
Fig 2. Death rate and surrounding 95% conﬁdence interval
(%, CI) in patients surviving repair stratiﬁed according to
AKISVS/ISCVS category and AKIRIFLE category. AKI, Acute kidney
injury; ISCVS, International Society for CardioVascular Surgery;
RIFLE, ‘Risk,’ ‘Injury,’ ‘Failure,’ ‘Loss,’ and ‘End-stage’;
SVS, Society for Vascular Surgery.
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to estimate baseline GFR and thereby baseline SCr. It
has been suggested that estimations of GFR such as
the MDRD equation should also be used to estimate
GFR for AKI.21 However, estimations of GFR were
only validated in subjects suffering from chronic kidneyinjury.22 Current estimations of GFR are invalid in a
clinical situation where renal function is rapidly chang-
ing, which was underlined by poor performance in sick
hospitalized patients23 and in critically ill patients with
early AKI.24
Previous studies. One previous study that assessed
AKIRIFLE after elective intervention for an asymptomatic
abdominal aortic aneurysm reported an incidence of
22% (15/69; 95% CI, 14%-33%).25 Two previous
studies that assessed AKIRIFLE in patients with an RAAA
reported an incidence of 80% (16/20; 95% CI, 58%-
92%)13 and of 76% (106/140; 95% CI, 66%-81%),14
which is comparable with our results. The present study
expands on these two previous studies in three ways. First,
patients were identiﬁed prospectively and consecutively.
Second, the number of patients included was considerably
larger (362 vs 2013 and 14014). Third, we applied the
original RIFLE deﬁnition and based AKI severity on SCr
and urine output criteria. Kopolovic et al used a modiﬁed
RIFLE deﬁnition based on SCr only.14 The use of the
RIFLE deﬁnition without the urine output criteria
signiﬁcantly underestimates the incidence and grade of
AKI, signiﬁcantly delays the diagnosis of AKI, and also
results in a higher AKI-related death rate.26
The need for RRT after OR of 26% (95% CI, 21%-
31%) was comparable with a previously reported RRT
rate after OR of 24% (95% CI, 17%-34%).27 The death
rate in patients receiving RRT was 54% (45/83; 95% CI,
44%-65%). This is lower if compared with previous studies
reporting a death rate between 75% and 87% after RRT in
patients with an RAAA.27,28 It is possible that caregivers at
Table IV. Multivariable logistic regression model to
assess the association between acute kidney injury (AKI)
deﬁned according to the ‘Risk,’ ‘Injury,’ ‘Failure,’ ‘Loss,’
and ‘End-stage’ (RIFLE) criteria and death
Variable Odds ratio (95% CI)
GAS 1.040 (1.018-1.062)a
APACHE II score
5-15 (n ¼ 99) Reference category
15-19 (n ¼ 94) 0.550 (0.183-1.656)
19-24 (n ¼ 93) 0.849 (0.260-2.773)
24-44 (n ¼ 76) 0.668 (0.207-2.154)
Use of vasopressors
None (n ¼ 120) Reference category
Low dose (n ¼ 162) 0.826 (0.372-1.835)
High dose (n ¼ 80) 2.795 (1.169-6.684)a
Fluid balance
<2 L (n ¼ 132) Reference category
>2 L or <5 L positive (n ¼ 130) 4.653 (1.886-11.485)a
>5 L positive (n ¼ 100) 9.927 (3.663-26.902)a
AKI deﬁned according to the RIFLE criteria
No (n ¼ 95) Reference category
Risk (n ¼ 71) 0.976 (0.311-3.061)
Injury (n ¼ 104) 1.986 (0.709-5.565)
Failure (n ¼ 92) 6.360 (2.231-18.130)a
APACHE, Acute Physiology and Chronic Health Evaluation; CI, conﬁ-
dence interval; GAS, Glasgow Aneurysm Score.
The model included 362 patients and 97 events, Hosmer and Lemeshow
test (8 degrees of freedom) P ¼ .21-.96, area under the receiver operating
characteristics curve, 0.87.
aP < .05.
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starting RRT.
In the Amsterdam Acute Aneurysm Trial, the need for
either temporary or permanent dialysis was observed
signiﬁcantly less often after EVAR than after OR.7 In
the present study, the incidence of AKI deﬁned using
the RIFLE criteria was lower after EVAR (63%; 95% CI,
51%-74%) than after OR (76%; 95% CI, 71%-81%).
Possibly, the problem of AKI is smaller after EVAR than
after OR. However, studies powered on the end point
AKI are needed to draw deﬁnite conclusions on this
matter.
Future research. The incidence of AKI was much
greater than anticipated. This indicates that minimizing
potential injury to the kidney pre-, intra-, and postopera-
tively could be an important focus of future research on
reducing the death rate after RAAA repair. SCr is a late
marker of kidney injury. It has been suggested that novel
biomarkers including interleukin-18, kidney injury
molecule-1, or N-acetyl-b-D-glucosaminidase might help
to detect AKI earlier and thereby improve AKI di-
agnostics.29 Treatment currently suggested for AKI is
mostly supportive, including maintenance of kidney
perfusion, treatment of obstruction, nutrition and glycemic
control, and avoiding nephrotoxins.30,31 Several studies
have addressed the balance between ﬂuid administration to
maintain renal perfusion and the damage caused by ﬂuid
overload. The risk of AKI is decreased with goal-directedtherapy for ﬂuid resuscitation,32 which comprises strictly
monitored early aggressive ﬂuid and vasoactive drug
administration. For patients with an RAAA, possible future
therapies to prevent AKI are mannitol,33 renal cooling if
suprarenal aortic-cross clamping is needed,34 or the use of
carbon dioxide as a contrast agent during EVAR.35
However, more evidence is required before deﬁnite con-
clusions can be drawn.
The RIFLE criteria have been updated recently.30
This update recommends classiﬁcation of patients treated
with RRT in the ‘Failure’ category. Only a few validation
studies have been done using these recommendations.
For this reason, we focused our study on the original and
most widely accepted RIFLE criteria and reported in
patients treated with RRT the AKI category before start
of RRT. As extra information, patients treated with
RRT were put into the ‘Failure’ category in accordance
with the most recent recommendations (Supplementary
Table I, online only). Future studies could determine the
clinical importance of the updated criteria compared with
the original RIFLE criteria in patients with an RAAA.
Limitations. A limitation of the present study was
that 60 patients of the Amsterdam ambulance region
were not referred to the AMC, OLVG, or VUMC and un-
derwent intervention at a regional hospital.15 In these
patients, the death rate was high (50%; 95% CI, 38%-62%).
It is probable that the incidence of AKI and the need for
RRT was greater in these patients than in the patients
included in the present study. However, data regarding
urine output were insufﬁciently accurate in the regional
hospitals, which was the reason these patients were not
included.
An exploratory analysis showed that age and blood
loss were greater in patients with AKI than in patients
without AKI (Supplementary Table II, online only).
Cardiac comorbidity and suprarenal aortic cross-
clamping were more prevalent in patients with AKI
than in patients without AKI. The preoperative shock
proﬁle represented by the GAS and the postoperative
shock proﬁle represented by the APACHE II score,
the use of vasopressors and the ﬂuid administration in
the ﬁrst 24 hours after intervention were also worse in
patients with AKI. Data collection was retrospective.
For this reason, we were reluctant to draw any solid con-
clusions regarding factors leading to AKI. We consider
AKI such a multifactorial syndrome that our statistical
methods fell short in the identiﬁcation of pre-, per-,
and postoperative risk factors.
The regression model (Table IV) should be inter-
preted with some caution. We tried to eliminate effects
of confounding factors. We aimed to represent the pa-
tients’ preoperative shock proﬁle with the GAS and the
postoperative shock proﬁle with the APACHE II score,
and the use of vasopressors and ﬂuid balance during the
ﬁrst 24 hours after intervention. These representations of
shock proﬁles might not be sufﬁciently accurate. More-
over, a low event rate meant that we could not include
more variables in the logistic regression model. We could
JOURNAL OF VASCULAR SURGERY
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blood loss during intervention, and administration of
medication.
CONCLUSIONS
The present study shows that most surgically treated
RAAA patients develop AKI deﬁned using the RIFLE
criteria. The RIFLE criteria identiﬁed a large group of pa-
tients with an increased risk of dying after adjustment for
shock proﬁle. The RIFLE criteria can thus be used to
improve risk stratiﬁcation in the postoperative period for
clinical and research purposes. Finally, these results indicate
that the problem of AKI is much larger than previously
anticipated and that minimizing potential injury to the kid-
ney could be an important focus of future research on
reducing the death rate after RAAA repair.
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Supplementary Table I (online only). The incidence of
acute kidney injury (AKI) deﬁned according to the
‘Risk,’ ‘Injury,’ ‘Failure,’ ‘Loss,’ and ‘End-stage’ (RIFLE)
criteria when patients treated with renal replacement
therapy (RRT) were put into the ‘Failure’ category
Outcome, % (No.; 95% CI)
Any AKI 74 (269/362; 70-79)
AKI category
Risk 23 (62/269; 18-28)
Injury 33 (88/269; 27-39)
Failure 44 (119/269; 38-50)
If AKI, reason
Urine output 34 (92/269; 29-40)
SCr 23 (63/269; 19-29)
Urine output and SCr 15 (40/269; 11-20)
RRT 28 (74/269; 23-33)
CI, Conﬁdence interval; SCr, serum creatinine.
Supplementary Table II (online only). Pre-, per-, and posto
kidney injury (AKI) deﬁned according to the ‘Risk,’ ‘Injury,’ ‘
No AKI (n ¼ 95)
Preoperative
Age 73 (66-78)
Cardiac comorbidity 32% (30/95)
Pulmonary comorbidity 25% (24/95)
Renal comorbidity 11% (10/95)
Cerebrovascular comorbidity 19% (18/95)
Diabetes 11% (10/93)
Hypertension 38% (35/93)
BMI 26.0 (23.9-27.8)
Lowest in-hospital SBP 110 (80-140)
CPR 5% (5/92)
Baseline SCr 90 (73-100)
GAS 83 (75-98)
Peroperative
If OR, suprarenal aortic cross clamping 26% (18/70)
If EVAR, contrast used, mL 127 (100-233)
Duration of interventionc 2:53 (2:25-3:25)
Blood loss, L 1.4 (0.5-3.5)
Postoperative
APACHE II at ICU admission 15 (12-18)
Use of vasopressors ﬁrst 24 hours after intervention
None 47% (45/95)
Low dose 50% (47/95)
High dose 3% (3/95)
Fluid balance ﬁrst 24 hours after intervention
<2 L positive 59% (56/95)
>2 L and <5 L 34% (32/95)
>5 L positive 7% (7/95)
APACHE, Acute Physiology and Chronic Health Evaluation; BMI, body mass i
repair; GAS, Glasgow Aneurysm Score; ICU, intensive care unit; OR, open repa
Continuous data are shown as median (interquartile range).
aMann-Whitney U test.
bc2 test.
cTime expressed as hours:minutes.
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1167.e1 van Beek et al November 2014perative characteristics of patients with and without acute
Failure,’ ‘Loss,’ and ‘End-stage’ (RIFLE) criteria
AKI (n ¼ 267) P Missing data
76 (70-81) <.01a 0
46% (122/265) .01b 1% (2/362)
22% (59/264) .56b 1% (3/362)
12% (32/264) .68b 1% (3/362)
15% (40/265) .38b 1% (2/362)
10% (27/263) .89b 2% (6/362)
45% (119/265) .22b 1% (4/362)
25.4 (23.4-27.6) .62a 39% (141/362)
90 (70-120) <.01a 4% (13/362)
9% (22/259) .34b 3% (11/362)
96 (74-100) .09a 0
94 (84-105) <.01a 4% (16/362)
41% (88/217) .03b 2% (7/294)
180 (120-250) .21a 60% (41/68)
2:55 (2:23-3:59) .21a 10% (35/362)
2.9 (1.0-5.7) <.01a 41% (148/362)
20 (17-25) <.01a 8% (30/362)
28% (75/267) <.01b 0
43% (115/267)
29% (77/267)
28% (76/267) <.01b 0
37% (98/267)
35% (93/267)
ndex; CPR, cardiopulmonary resuscitation; EVAR, endovascular aneurysm
ir; SBP, systolic blood pressure; SCr, serum creatinine.
